Charles River Laboratories International, Inc.
CRL
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufactuā¦ read more
Healthcare
Diagnostics & Research
26 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$278.26
Price+1.93%
$5.26
1Y
Price
Market Cap
$13.403b
Large
Price/Earnings 3y Avg5y Avg
28.1x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+15.0%
EBITDA Margin-0.1%
Net Profit Margin+14.8%
Free Cash Flow Margin+15.0%
EBITDA Margin-0.1%
Net Profit Margin+14.8%
Free Cash Flow MarginRevenue
$3.999b
-0.4%
1y CAGR-1.1%
3y CAGR+0.2%
5y CAGREarnings
-$238.458m
-65.2%
1y CAGR-554.9%
3y CAGR-416.8%
5y CAGREPS
-$4.85
-66.7%
1y CAGR-573.2%
3y CAGR-430.6%
5y CAGRBook Value
$2.846b
$7.532b
Assets$4.686b
Liabilities$3.028b
DebtDebt to Assets
40.2%
13.7x
Debt to EBITDAFree Cash Flow
$370.605m
-28.5%
1y CAGR+4.1%
3y CAGR+9.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company